Retinai, the developer of software solutions to accelerate and support clinical and pharmaceutical research, clinical workflows and biomarker based decision support, has announced a collaboration with Novartis to provide artificial intelligence solutions in ophthalmology.
Congratulations to Carlos Ciller and the rest of the team!
Read more here.